Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15607368rdf:typepubmed:Citationlld:pubmed
pubmed-article:15607368lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0368761lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0079633lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C1511615lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C0302891lld:lifeskim
pubmed-article:15607368lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:15607368pubmed:issue2lld:pubmed
pubmed-article:15607368pubmed:dateCreated2004-12-20lld:pubmed
pubmed-article:15607368pubmed:abstractTextInteractions between native human acute myelogenous leukemia (AML) blasts and nonleukemic cells in the bone marrow microenvironment seem important both for disease development chemosensitivity. Native human AML blasts from consecutive patients were cultured with normal human bone marrow stromal cells and two fibroblast lines (HFL1 and Hs27) separated by a semipermeable membrane. This bidirectional crosstalk via the cytokine network between AML blasts and fibroblasts caused (i) increased proliferation, (ii) mediated antiapoptotic signalling and (iii) increased local levels of proangiogenic IL8.lld:pubmed
pubmed-article:15607368pubmed:languageenglld:pubmed
pubmed-article:15607368pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15607368pubmed:citationSubsetIMlld:pubmed
pubmed-article:15607368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15607368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15607368pubmed:statusMEDLINElld:pubmed
pubmed-article:15607368pubmed:monthFeblld:pubmed
pubmed-article:15607368pubmed:issn0145-2126lld:pubmed
pubmed-article:15607368pubmed:authorpubmed-author:GlenjenNilsNlld:pubmed
pubmed-article:15607368pubmed:authorpubmed-author:GjertsenBjørn...lld:pubmed
pubmed-article:15607368pubmed:authorpubmed-author:BruserudOyste...lld:pubmed
pubmed-article:15607368pubmed:authorpubmed-author:RyningenAnita...lld:pubmed
pubmed-article:15607368pubmed:authorpubmed-author:WergelandLine...lld:pubmed
pubmed-article:15607368pubmed:issnTypePrintlld:pubmed
pubmed-article:15607368pubmed:volume29lld:pubmed
pubmed-article:15607368pubmed:ownerNLMlld:pubmed
pubmed-article:15607368pubmed:authorsCompleteYlld:pubmed
pubmed-article:15607368pubmed:pagination185-96lld:pubmed
pubmed-article:15607368pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:meshHeadingpubmed-meshheading:15607368...lld:pubmed
pubmed-article:15607368pubmed:year2005lld:pubmed
pubmed-article:15607368pubmed:articleTitleIn vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.lld:pubmed
pubmed-article:15607368pubmed:affiliationDivision for Hematology, Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway. anita.ryningen@helse-bergen.nolld:pubmed
pubmed-article:15607368pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15607368pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3576entrezgene:pubmedpubmed-article:15607368lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15607368lld:entrezgene
lhgdn:association:7524lhgdn:found_inpubmed-article:15607368lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15607368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15607368lld:pubmed